The role of the VEGF-C/VEGFR-3 axis in cancer progression.
about
Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signalingVascular endothelial growth factor as an anti-angiogenic target for cancer therapyE2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.The -1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland.Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasisNovel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.In silico models of cancerGlobal gene expression profiles of canine macrophages and canine mammary cancer cells grown as a co-culture in vitroLysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway.Ziv-aflibercept in metastatic colorectal cancerImpact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.The first Tianjin, China forum on tumor microenvironment.Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental modelsNuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivAqueous Extract of Paeonia suffruticosa Inhibits Migration and Metastasis of Renal Cell Carcinoma Cells via Suppressing VEGFR-3 Pathway.Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathwayVascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma.Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancerRole of vascular endothelial growth factor receptor-3/Flt-4 in early-stage cervical cancer.Inhibition of BMP signaling suppresses metastasis in mammary cancerMicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.Inhibition of Metastatic Potential in Breast Carcinoma In Vivo and In Vitro through Targeting VEGFRs and FGFRs.Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?Lymphatic Vessel Density and Vascular Endothelial Growth Factor Expression in Squamous Cell Carcinomas of Lip and Oral Cavity: A Clinicopathological Analysis with Immunohistochemistry Using Antibodies to D2-40, VEGF-C and VEGF-D.Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C/VEGFR-3 signaling pathway.Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
P2860
Q27333172-C1950886-752E-449B-87AF-9ADCF4027EC9Q28078716-BAB552F5-44F9-4D8D-8D38-B18BAFD93347Q30455612-3BD21AC7-B87F-47B9-B9E9-7A038A61FB2DQ30564026-7A50C256-7D33-4BF5-B27D-7447C1DBBE6CQ30981990-27F36125-F94A-44FC-A690-4C7632377D33Q31132489-6D40886D-6357-45A5-BBA0-FEB57E0EDFEBQ32184965-B5832FDF-1F73-4BF8-9656-2FEBF480F7F1Q33539996-1864499C-8F30-4EFA-A73D-B34B14C6DCA1Q33935434-14A8777C-60FA-4CBC-A78D-F7D616B3F218Q33944562-81E5442C-4243-42FF-A953-6FBAF47D068DQ33967503-D83DB844-DA66-4C1E-A13F-03644A16508FQ33977081-063A6032-BC0A-4B0D-9611-7AB3387AFA6AQ34026770-0DB0475F-14E7-4EB7-8B1C-48EC7A49BB19Q34049659-AB883E49-39A3-470D-8058-CC0A06D6D3DBQ34137584-CC0BC769-5D0F-47FD-934E-21A78CC1094AQ34165688-8F2D1FFD-3204-47F0-9988-ABF8CA8EBA19Q34387665-AB3F3156-CDAE-49FD-B073-EA603A854B88Q34406774-7B666731-E6C3-4EA6-B8E4-0C41C9BED277Q34500778-9DF56786-F125-468A-9845-DA92D53CA7E6Q34658579-4552724B-0488-40CF-9B1D-81F9235F4A2DQ34672891-E4DF6626-45B0-44F9-B6EF-4FEA9233990BQ34786304-D15C5D85-A815-48ED-ADA4-3651326C5D19Q34788361-E0BAEA7D-570C-44D3-9F80-53B52C7BD9F1Q35000337-D4DFFE8C-804B-414D-A766-60FEB71CFB0CQ35000353-A9C15F68-7447-4A68-8489-B31EDE4510A0Q35695946-59CA266C-A922-42DE-9CDF-15E6CD585A45Q35794165-60F1F4B5-20F7-47FF-92FC-0DC864D28D2CQ35913266-3B217969-ED9B-4AA1-A0D6-F16DA35BAB9FQ35921437-E01E68BE-E97A-46AC-ACE3-785054D52346Q35929801-0E94AE36-9E1E-43C9-92AF-BFBA4DD559AAQ36085903-07089BF2-FCB0-45DB-B671-719C84CE45B7Q36216694-E5A2ECAF-255C-48A1-A849-04D6A95927F8Q36398681-80ABDAE7-BC3D-4B7E-8A6F-5A4C0C3847D2Q36545778-B476369E-50B2-45AE-83E6-74D02A0C2F35Q36938939-441B79FA-8BBE-4999-9F31-AE9DD6E8AC33Q37094060-21725771-69DB-4933-A32E-64A5EC1BA4B4Q37140785-776E78A0-621B-4E5A-B901-9EEBF5A59BD6Q37287567-B42D859A-F978-42F1-B6D5-F4ED97C9166DQ37328125-2EBE5021-4C7A-44F6-8428-CCAB399AB5E2Q37381588-6AAF4166-C3D1-4583-8A4E-86084398AA89
P2860
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@ast
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@en
type
label
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@ast
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@en
prefLabel
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@ast
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@en
P2093
P2860
P921
P356
P1476
The role of the VEGF-C/VEGFR-3 axis in cancer progression.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603487
P407
P577
2006-12-12T00:00:00Z
2007-02-26T00:00:00Z